Search Results - "HÖNIG, Arnd"

Coordinate Regulation of Transcription and Splicing by Steroid Receptor Coregulators by Auboeuf, Didier, Hönig, Arnd, Berget, Susan M., O'Malley, Bert W.

“…Recent observations indicating that promoter identity influences alternative RNA-processing decisions have created interest in the regulatory interactions…”
Get full text

Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells by Schmidt, Sebastian, Liu, Guoxing, Liu, Guilai, Yang, Wenting, Honisch, Sabina, Pantelakos, Stavros, Stournaras, Christos, Hönig, Arnd, Lang, Florian

“…Mechanisms underlying therapy resistance of tumor cells include protein kinase Akt. Putative Akt targets include store-operated Ca(2+)-entry (SOCE)…”
Get full text

Regulation of Alternative Splicing by the ATP-Dependent DEAD-Box RNA Helicase p72 by Hönig, Arnd, Auboeuf, Didier, Parker, Marjorie M, O'Malley, Bert W, Berget, Susan M

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Cervical endometriosis associated with malignant pleural mesothelioma mimicking cervical cancer—Occam’s razor or the “third man” by Engel, Jörg B., M.D, Heuer, Stefan, M.D, Segerer, Sabine, M.D, Rauthe, Stephan, M.D, Dietl, Johannes, M.D, Hönig, Arnd, M.D

“…Objective To illustrate pitfalls in the diagnosis of endometriosis and cervical cancer. Design Case report. Setting University hospital, department of…”
Get full text

Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells by REIM, Florian, DOMBROWSKI, Yvonne, BECKER, Jürgen C, HÖNIG, Arnd, WISCHHUSEN, Jörg, RITTER, Cathrin, BUTTMANN, Mathias, HÄUSLER, Sebastian, OSSADNIK, Monika, KROCKENBERGER, Mathias, BEIER, Dagmar, BEIER, Christoph P, DIETL, Johannes

“…Although trastuzumab (Herceptin) has substantially improved the overall survival of patients with mammary carcinomas, even initially well-responding tumors…”
Get full text

Macrophage Migration Inhibitory Factor Contributes to the Immune Escape of Ovarian Cancer by Down-Regulating NKG2D by Krockenberger, Mathias, Dombrowski, Yvonne, Weidler, Claudia, Ossadnik, Monika, Honig, Arnd, Hausler, Sebastian, Voigt, Heike, Becker, Jurgen C, Leng, Lin, Steinle, Alexander, Weller, Michael, Bucala, Richard, Dietl, Johannes, Wischhusen, Jorg

“…The proinflammatory cytokine macrophage migration inhibitory factor (MIF) stimulates tumor cell proliferation, migration, and metastasis; promotes tumor…”
Get full text

HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials by Dent, Susan, Oyan, Basak, Honig, Arnd, Mano, Max, Howell, Sacha

“…Abstract Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence with chemotherapy improves overall survival in metastatic and early…”
Get full text

3.0 Tesla breast magnetic resonance imaging in patients with nipple discharge when mammography and ultrasound fail by Lubina, Nóra, Schedelbeck, Ulla, Roth, Anne, Weng, Andreas Max, Geissinger, Eva, Hönig, Arnd, Hahn, Dietbert, Bley, Thorsten Alexander

“…Objectives To compare 3.0 Tesla breast magnetic resonance imaging (MRI) with galactography for detection of benign and malignant causes of nipple discharge in…”
Get full text

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity by Häusler, Sebastian F. M., Montalbán del Barrio, Itsaso, Strohschein, Jenny, Anoop Chandran, P., Engel, Jörg B., Hönig, Arnd, Ossadnik, Monika, Horn, Evi, Fischer, Birgitt, Krockenberger, Mathias, Heuer, Stefan, Seida, Ahmed Adel, Junker, Markus, Kneitz, Hermann, Kloor, Doris, Klotz, Karl-Norbert, Dietl, Johannes, Wischhusen, Jörg

“…The ectonucleotidases CD39 and CD73 degrade immune stimulatory ATP to adenosine that inhibits T and NK cell responses via the A 2A adenosine receptor…”
Get full text

Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells by Grunewald, Thomas G.P., Kammerer, Ulrike, Schulze, Elfriede, Schindler, Detlef, Honig, Arnd, Zimmer, Michael, Butt, Elke

“…LIM and SH3 protein (LASP-1), initially identified from human breast cancer, is a specific focal adhesion protein involved in cell migration. LASP-1 is an…”
Get full text

Abstract P5-11-15: Estetrol for treatment of advanced ER+/HER2- breast cancer by Schmidt, Marcus, Hönig, Arnd, Zimmerman, Yvette, Verhoeven, Carole, Almstedt, Katrin, Battista, Marco, Lenhard, Hans Georg, Krijgh, Jan, Bennink, Herjan Coelingh

“…Abstract Introduction: A high dose of the fetal estrogen estetrol (E4) is anticipated to have anti-tumor effects in patients with advanced, anti-estrogen…”
Get full text

Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma by Grunewald, Thomas G P, Kammerer, Ulrike, Kapp, Michaela, Eck, Matthias, Dietl, Johannes, Butt, Elke, Honig, Arnd

“…LIM and SH3 protein 1 (LASP-1), initially identified from human breast cancer, is a specific focal adhesion protein involved in cell proliferation and…”
Get full text

Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases by Cotarelo, Cristina L, Schad, Arno, Schmidt, Marcus, Hönig, Arnd, Sleeman, Jonathan P, Thaler, Sonja

“…Oncogene-induced senescence is thought to constitute a barrier to carcinogenesis by arresting cells at risk of malignant transformation. However, numerous…”
Get full text

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial by Harbeck, N., Fasching, P.A., Wuerstlein, R., Degenhardt, T., Lüftner, D., Kates, R.E., Schumacher, J., Räth, P., Hoffmann, O., Lorenz, R., Decker, T., Reinisch, M., Göhler, T., Staib, P., Gluz, O., Schinköthe, T., Schmidt, M., Kieback, Dirk Günter, van Mackelenbergh, Marion Tina, Hielscher, Carsten, Ugur, Mustafa Celalettin, Uleer, Christoph, Zahn, Mark-Oliver, Meyer, Ralf, Kraudelt, Susanne, Stefek, Andrea, Pink, Daniel, Just, Marianne, Kolberg, Hans-Christian, Fehm, Tanja, Malter, Wolfram, Warm, Mathias, Forstbauer, Helmut, Behringer, Dirk, Wortmann, Anke, Rom, Joachim, Lehnert, Antje, Ackermann, Sven, Guth, Dagmar, Simon, Eike, Dünnebacke, Jan, Hönig, Arnd, Ehscheidt, Peter, Gnauert, Karsten, Kühn, Thorsten, von Abel, Ekkehard, Hartkopf, Andreas, Karck, Ulrich, Negwer, Martina, Wacker, Jürgen, Welslau, Manfred, Sagasser, Jaqueline, Heinrichm, Bernhard, Brucker, Cosima, Stauder, Heribert, Gröll, Isolde, Felberbaum, Ricardo, Popovic, Milos, Baerens, Dirk-Toralf, Söling, Ulrike, Zaiss, Matthias, Rauh, Jaqueline, Fietz, Thomas, Schröder, Jan, Voß, Hermann, Mohm, Johannes, Neef, Ute, Rieger, Lorenz, Distelrath, Andrea, Nusch, Arnd, Schmidt, Burkhard, Lüdtke-Heckenkamp, Kerstin, Berghorn, Michael, Busch, Steffi, Schock, Caroline, Metz, Michael, Lorenz, Andreas, Uhlig, Jens, Otremba, Burkhard

“…The multicenter, randomized, phase IV, intergroup AGO-B WSG PreCycle trial (NCT03220178) evaluated the impact of CANKADO-based electronic patient-reported…”
Get full text

Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion by Häusler, Sebastian Fm, Del Barrio, Itsaso Montalbán, Diessner, Joachim, Stein, Roland G, Strohschein, Jenny, Hönig, Arnd, Dietl, Johannes, Wischhusen, Jörg

“…The ectonucleotidases CD39 and CD73 degrade ATP to adenosine which inhibits immune responses via the A2A adenosine receptor (ADORA2A) on T and NK cells. The…”
Get full text

Dendritic cells: elegant arbiters in human reproduction by Segerer, Sabine E, Staib, Claudia, Kaemmerer, Ulrike, Frambach, Torsten, Honig, Arnd, Dietl, Johannes, Rieger, Lorenz

“…The female reproductive tract represents a great challenge to the residing immune cells: Concomitantly, those immune-competent cells have to provide…”
Get more information

Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial by Coombes, R Charles, Tovey, Holly, Kilburn, Lucy, Mansi, Janine, Palmieri, Carlo, Bartlett, John, Hicks, Jonathan, Makris, Andreas, Evans, Abigail, Loibl, Sibylle, Denkert, Carsten, Murray, Elisabeth, Grieve, Robert, Coleman, Robert, Borley, Annabel, Schmidt, Marcus, Rautenberg, Beate, Kunze, Catarina Alisa, Rhein, Uwe, Mehta, Keyur, Mousa, Kelly, Dibble, Tessa, Lu, Xiao Lou, von Minckwitz, Gunter, Bliss, Judith M

“…Patients with breast cancer remain at risk of relapse after adjuvant therapy. Celecoxib has shown antitumor effects in preclinical models of human breast…”
Get more information

Must we press on until a young mother dies? Remifentanil patient controlled analgesia in labour may not be suited as a "poor man's epidural" by Kranke, Peter, Girard, Thierry, Lavand'homme, Patricia, Melber, Andrea, Jokinen, Johanna, Muellenbach, Ralf M, Wirbelauer, Johannes, Hönig, Arnd

“…The epidural route is still considered the gold standard for labour analgesia, although it is not without serious consequences when incorrect placement goes…”
Get full text

Papillary squamotransitional cell carcinoma of the vagina by Niederle, Bernhard, Rauthe, Stephan, Engel, Jörg B., Krockenberger, Matthias, Dietl, Johannes, Honig, Arnd

“…A case of a papillary squamotransitional cell carcinoma (PSTCC) of the vagina with a follow‐up of 3 years is presented here. The characteristics of this case…”
Get full text

Targeting of pre-existing and induced breast cancer stem cells with HER2-specific immunotherapeutics and NK cells (165.18) by Wischhusen, Jörg, Diessner, Joachim, Becker, Kathrin, Hönig, Arnd

“…Abstract Trastuzumab (Herceptin®) has substantially improved the overall survival of patients with mammary carcinoma. While recruitment of NK cells and…”
Get full text